Inhaler
Latest AstraZeneca UK Limited Patents:
- Methods based on the detection of RAD51 foci in tumor cells
- Systems and methods for dispensing a statin medication over the counter
- Systems and methods for dispensing a statin medication over the counter
- COMBINATION OF ANTIBODY-DRUG CONJUGATE AND PARP1 SELECTIVE INHIBITOR
- Methods for lowering blood sugar with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition
FIG. 1 is a front perspective view from above and to one side of an inhaler showing our new design, shown in open configuration;
FIG. 2 is a rear perspective view from above and the other side of the inhaler, shown in open configuration;
FIG. 3 is a side elevational view thereof, the opposite side elevational view being a mirror image thereto;
FIG. 4 is a front elevational view thereof;
FIG. 5 is a top plan view thereof;
FIG. 6 is a bottom plan view thereof;
FIG. 7 is a rear elevational view thereof;
FIG. 8 is a front perspective view from above and to one side of the inhaler, shown in closed configuration;
FIG. 9 is a rear perspective view from above and the other side the inhaler, shown in closed configuration;
FIG. 10 is a side elevational view thereof, the opposite side elevational view being a mirror image thereto;
FIG. 11 is a front elevational view thereof;
FIG. 12 is a top plan view thereof;
FIG. 13 is a bottom plan view thereof; and,
FIG. 14 is a rear elevational view thereof.
Claims
The ornamental design for an inhaler, as shown and described.
Type: Grant
Filed: Mar 6, 2000
Date of Patent: Mar 27, 2001
Assignee: AstraZeneca UK Limited (London)
Inventors: Malin Andersson (Stockholm), Maria Benktzon (Sollentuna), Sven-Eric Juhlin (Stockholm)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Nixon & Vanderhye
Application Number: 29/119,606
International Classification: 2902;